Clinical Trial

Depression, Illness Perception, and Erectile Dysfunction Outcomes

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated August 12, 2025 (before its estimated August 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this observational study is to evaluate the impact of illness perception and depressive symptoms on treatment outcomes in adult male patients diagnosed with erectile dysfunction (ED). The main questions it aims to answer are: Is there a relationship between negative illness perception and increased severity of depressive symptoms in ED patients? Does the change in illness perception over time correlate with changes in erectile function and depression levels? Participants will: Complete the IIEF-5 (International Index of Erectile Function - 5) to assess erectile dysfunction severity, Complete the B-IPQ (Brief Illness Perception Questionnaire) to evaluate their cognitive and emotional representations of ED, Complete the PHQ-9 (Patient Health Questionnaire - 9) to measure depressive symptoms, Repeat these assessments at baseline and at a 1-month follow-up. This study does not involve any intervention or comparison group. It is designed to track psychological and clinical changes over time and explore modifiable psychological predictors in the management of ED.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-21; most recent amendment 2025-08-06.
Trial Details
NCT Number NCT06996925
Lead Sponsor Haseki Training and Research Hospital
Conditions Erectile Dysfunction, Depression, Perception and Beliefs
Enrollment 120 participants
Start Date 2025-03-31
Primary Completion 2025-08-31 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-12